Spring Intro 2023

30/03/2023

Target product profile/Target outcome TPP

Product Vision

As a next generation therapy, xxxx will be transformative to the treatment of….

Reasons to Believe

• Superior efficacy • Durability of on-drug efficacy • Locally acting • Placebo like efficacy • Oral

Franchise Fit

lead asset in a potentially multi-asset franchise that expands therapy presence

Indication

Geographies

US, EU 5, Canada, Japan – other countries to be prioritized as required

Unmet Need Competitive Threats

More efficacious and durable therapies, safer, new MOAs, oral

Market Landscape

Evolving treatment guidelines including new endpoints

The Organisation for Professionals in Regulatory Affairs

7

What is Regulatory Strategy ?

The Organisation for Professionals in Regulatory Affairs The Organisation for

Professionals i Regulatory Affairs

8